Tylenol in Pregnancy and Autism: What Evidence Shows
The FDA plans to notify clinicians about a possible link between prenatal acetaminophen (Tylenol) use and higher rates of neurodevelopmental conditions such as autism and ADHD.
The whole archive, newest first
The FDA plans to notify clinicians about a possible link between prenatal acetaminophen (Tylenol) use and higher rates of neurodevelopmental conditions such as autism and ADHD.
Two randomized clinical trials published September 14 in The Lancet Diabetes & Endocrinology found that larger weekly doses of semaglutide produced substantially greater weight loss…
Health officials recommend that nearly everyone who is eligible get a flu vaccine this fall, even though some forecasts suggest the 2025–2026 season may be less severe than the…
A 15-year, population-based Mayo Clinic study (OCTOPUS: Olmsted Cardiac Troponin in Persons Under Sixty-six) found that heart attacks in people 65 and younger — especially women —…
A recent study suggests that GLP-1 weight-loss medications such as semaglutide (the active agent in Ozempic and Wegovy) may produce smaller or shorter-lived benefits for people whose…
Weighted vests are widely used in gyms, parks, and on social media, often promoted for benefits like better posture, stronger bones, more calories burned, and improved strength and…
A large analysis of more than 4 million adults found that those with a history of cannabis-related diagnoses had almost four times the risk of developing type 2 diabetes over five…
Julianne Moore won an Academy Award in 2015 for her portrayal of a linguistics professor diagnosed with early-onset Alzheimer’s in the film Still Alice.
A small pilot trial at Ohio State University suggests a ketogenic diet could substantially reduce depressive symptoms in young adults.
Researchers at the University of Michigan report a mechanism by which cigarette smoke–related chemicals can promote pancreatic cancer by reprogramming the immune system to favor tumor…
A Gallup poll finds that more than 18% of U.S. adults currently report having or being treated for depression — a level that has remained historically high since 2024.
A new analysis from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, published Sept.